AAV-based treatment of cholesterol-related disorders
US9272053B2 · kind B2 · utility
31Cited by
42References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 2011 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Oct 8, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention in some aspects relates to methods and compositions for assessing the effectiveness of miRNA inhibitors. In other aspects of the invention, methods and compositions for treating cholesterol related disorders are provided. In one aspect of the invention, miRNA inhibitors against miR-122 and rAAV-based compositions comprising the same are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.